Sanofi once-weekly Altuviiio approved in Japan for hemophilia A Ruchika Sharma25 Sept 2023 5:01 PM ISTParis: Sanofi has announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO...
Health Bulletin 10/August/2023 Roshni Dhar10 Aug 2023 4:51 PM ISTHere are the top health stories for the day:Air we breath, and its deteriorating quality is associated with increased antibiotic resistanceCurbing...
Sanofi-AstraZeneca Beyfortus gets unanimous US CDC Advisory Committee recommendation to prevent RSV in neonates, infants Ruchika Sharma4 Aug 2023 1:09 PM ISTParis: Sanofi has recently announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization...
Sanofi to acquire Qunol Ruchika Sharma28 July 2023 1:30 PM ISTParis: Sanofi has announced it has entered into a definitive agreement to acquire ownership of Qunol, a U.S.-based brand in health & wellness....
UK probes Novo Nordisk Ozempic, Saxenda over suicidal, self-harming thoughts Ruchika Sharma27 July 2023 2:30 PM ISTLondon: Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients...
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
Sanofi Dupixent gets nod in India for treatment of adults with moderate-to-severe atopic dermatitis Ruchika Sharma11 July 2023 1:12 PM ISTDupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.
First trial over heartburn drug Zantac cancer claims expected in November Ruchika Sharma3 July 2023 2:30 PM ISTNew York: The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state...
CDSCO Panel Approves Sanofi's Protocol Amendment Proposal for SAR443122 Dr. Divya Colin2 July 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim Ruchika Sharma21 Jun 2023 1:30 PM ISTThere is no evidence of consumer harm from real world use of Zantac as a result of any NDMA contamination.
AstraZeneca-Sanofi Nirsevimab unanimously recommended by USFDA Advisory Committee for prevention of RSV in infants Ruchika Sharma9 Jun 2023 1:30 PM ISTLondon: The US Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) has voted unanimously 21 to 0 that AstraZeneca and...
New Sandoz Board of Directors appointed Ruchika Sharma15 May 2023 2:57 PM ISTBasel: The Novartis Board of Directors has approved the recommendations of the Sandoz Chairman-designate, Gilbert Ghostine, on the structure of the...
